150 related articles for article (PubMed ID: 37138436)
1. Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19.
Abolfazli S; Ebrahimi N; Morabi E; Asgari Yazdi MA; Zengin G; Sathyapalan T; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2024; 31(21):3132-3148. PubMed ID: 37138436
[TBL] [Abstract][Full Text] [Related]
2. H
Yang G
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C244-C249. PubMed ID: 32515982
[TBL] [Abstract][Full Text] [Related]
3. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
4. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy.
Dugbartey GJ; Alornyo KK; Ohene BO; Boima V; Antwi S; Sener A
Nitric Oxide; 2022 Mar; 120():16-25. PubMed ID: 35032641
[TBL] [Abstract][Full Text] [Related]
5. Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.
Jiang WP; Deng JS; Yu CC; Lin JG; Huang GJ
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892254
[TBL] [Abstract][Full Text] [Related]
6. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
Muralidar S; Gopal G; Visaga Ambi S
J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732
[TBL] [Abstract][Full Text] [Related]
7. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
Choi Y; Shin B; Kang K; Park S; Beck BR
Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H
Citi V; Martelli A; Brancaleone V; Brogi S; Gojon G; Montanaro R; Morales G; Testai L; Calderone V
Br J Pharmacol; 2020 Nov; 177(21):4931-4941. PubMed ID: 32783196
[TBL] [Abstract][Full Text] [Related]
10. Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester.
Kumar V; Sari AN; Gupta D; Ishida Y; Terao K; Kaul SC; Vrati S; Sundar D; Wadhwa R
Curr Top Med Chem; 2024; 24(9):830-842. PubMed ID: 38279743
[TBL] [Abstract][Full Text] [Related]
11. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
[TBL] [Abstract][Full Text] [Related]
12. The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS-CoV-2 and Its Potential Cell Surface Receptors.
Dai J; Teng X; Jin S; Wu Y
Oxid Med Cell Longev; 2021; 2021():7866992. PubMed ID: 34497683
[TBL] [Abstract][Full Text] [Related]
13. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
14. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Gupta VK; Murthy MK; Patil S
Curr Drug Targets; 2021; 22(10):1149-1157. PubMed ID: 33243116
[TBL] [Abstract][Full Text] [Related]
15. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
16. Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus.
Kumar V; Sari AN; Meidinna HN; Dhanjal JK; Subramani C; Basu B; Kaul SC; Vrati S; Sundar D; Wadhwa R
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34647577
[TBL] [Abstract][Full Text] [Related]
17. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.
Zhuo LS; Wang MS; Yang JF; Xu HC; Huang W; Shang LQ; Yang GF
Top Curr Chem (Cham); 2021 Apr; 379(3):23. PubMed ID: 33886017
[TBL] [Abstract][Full Text] [Related]
18. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
19. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
Coban MA; Morrison J; Maharjan S; Hernandez Medina DH; Li W; Zhang YS; Freeman WD; Radisky ES; Le Roch KG; Weisend CM; Ebihara H; Caulfield TR
Biomolecules; 2021 May; 11(6):. PubMed ID: 34071060
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
Suárez-Fariñas M; Tokuyama M; Wei G; Huang R; Livanos A; Jha D; Levescot A; Irizar H; Kosoy R; Cording S; Wang W; Losic B; Ungaro RC; Di'Narzo A; Martinez-Delgado G; Suprun M; Corley MJ; Stojmirovic A; Houten SM; Peters L; Curran M; Brodmerkel C; Perrigoue J; Friedman JR; Hao K; Schadt EE; Zhu J; Ko HM; Cho J; Dubinsky MC; Sands BE; Ndhlovu L; Cerf-Bensusan N; Kasarskis A; Colombel JF; Harpaz N; Argmann C; Mehandru S
Gastroenterology; 2021 Jan; 160(1):287-301.e20. PubMed ID: 32980345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
